In this Q&A we examine Right-to-Try drug laws and discuss tips for clinicians with terminally ill patients who have exhausted all their therapy options.
Arthur Caplan, PhD
Advertisement
Articles by Arthur Caplan, PhD
The cost of cancer treatment has at least doubled since 1987 and there does not appear to be any hint that cancer care costs will decline. In this podcast we discuss the reasons for the increase in costs, as well as the ethics of cancer care cost containment.
Advertisement
Latest Updated Articles
Ethics of Cost Containment for Cancer TherapiesPublished: August 23rd 2012 | Updated:
Medical Ethicist Arthur Caplan Explains Why He Opposes ‘Right-to-Try’ LawsPublished: January 15th 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
What Were the Key Presentations at ESMO 2025? Oncology Experts Discuss
2
Porustobart/Tislelizumab Elicits Responses in MSS Metastatic Colorectal Cancer
3
An Oncodermatologist’s Perspective on Dermatological Toxicities in Breast Cancer
4
What Path to Approval Has Dasatinib Taken in CML/ALL?
5
